Skip to main content
logo
Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.46
-0.80 (-4.38%)
Oct 13, 2026, 1:48 PM EDT - Market open

Odyssey Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.12.984.471.04-
Revenue Growth
-96.70%-33.45%331.24%--
Gross Profit
-120.62-118.2-108.11-111.24-101.52
Operating Income
-154.83-155.72-135.22-133.44-122.54
Net Income
-160.03-148.65-130.4-130.92-124.67
Earnings Per Share
-14.05-50.13-161.59-202.04-278.39
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
433.07216.56129.35216.1241.04
Total Debt
24.8327.1131.0134.3840.86
Net Cash (Debt)
408.24189.4598.35181.72200.18
Net Cash Growth
232.42%92.63%-45.88%-9.22%-
Net Cash Per Share
35.8563.89121.87280.43447.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-132.13-129.47-117.47-112.73-99.84
Capital Expenditures
-0.61-1.23-0.76-5.06-13.03
Free Cash Flow
-132.74-130.7-118.24-117.78-112.87
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Margin
-156392.93%-5232.39%-3023.77%-12867.79%-
Pretax Margin
-162695.96%-5026.01%-2881.31%-12101.35%-
Profit Margin
-161643.43%-4994.86%-2915.94%-12624.88%-
FCF Margin
-134079.80%-4391.80%-2643.89%-11358.15%-